Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) and PetMed Express (NASDAQ:PETS – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, valuation and risk.
Profitability
This table compares Guardian Pharmacy Services and PetMed Express’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Guardian Pharmacy Services | N/A | N/A | N/A |
PetMed Express | -0.37% | -1.00% | -0.60% |
Insider & Institutional Ownership
73.3% of PetMed Express shares are owned by institutional investors. 1.1% of PetMed Express shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Analyst Ratings
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Guardian Pharmacy Services | 0 | 0 | 3 | 0 | 3.00 |
PetMed Express | 1 | 1 | 0 | 0 | 1.50 |
Guardian Pharmacy Services currently has a consensus target price of $22.00, suggesting a potential downside of 2.61%. PetMed Express has a consensus target price of $3.50, suggesting a potential downside of 33.46%. Given Guardian Pharmacy Services’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Guardian Pharmacy Services is more favorable than PetMed Express.
Valuation and Earnings
This table compares Guardian Pharmacy Services and PetMed Express”s gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Guardian Pharmacy Services | $1.17 billion | 1.22 | N/A | N/A | N/A |
PetMed Express | $259.34 million | 0.42 | -$7.46 million | ($0.06) | -87.67 |
Guardian Pharmacy Services has higher revenue and earnings than PetMed Express.
Summary
Guardian Pharmacy Services beats PetMed Express on 8 of the 10 factors compared between the two stocks.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
About PetMed Express
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.